Eli Lilly and Company (TSX:LLY)
Canada · Delayed Price · Currency is CAD 48.29
-0.38 (-0.78%)
Nov 6, 2026, 4:00 PM EST
Eli Lilly and Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 86,462 | 65,179 | 45,043 | 34,124 | 28,541 | 28,318 | |
Revenue Growth | 45.51% | 44.70% | 32.00% | 19.56% | 0.79% | 15.40% |
Cost of Revenue | 14,150 | 11,052 | 8,418 | 7,082 | 6,630 | 6,973 |
Gross Profit | 72,312 | 54,127 | 36,625 | 27,042 | 21,912 | 21,345 |
Selling, General & Admin | 12,620 | 11,094 | 8,594 | 7,404 | 6,068 | 6,142 |
Research & Development | 15,377 | 13,337 | 10,991 | 9,313 | 7,191 | 6,931 |
Operating Expenses | 27,997 | 24,431 | 19,585 | 16,717 | 13,258 | 13,073 |
Operating Income | 44,315 | 29,696 | 17,040 | 10,325 | 8,653 | 8,273 |
Interest Expense | -383 | - | - | - | -331.6 | -339.8 |
Interest & Investment Income | - | - | - | - | 62.8 | 25.4 |
Currency Exchange Gain (Loss) | -481 | - | - | - | -191.3 | -204.6 |
Other Non Operating Income (Expenses) | 757 | -571 | -219 | 97 | 177 | 256 |
EBT Excluding Unusual Items | 44,208 | 29,125 | 16,821 | 10,422 | 8,370 | 8,010 |
Merger & Restructuring Charges | - | - | - | - | - | -13 |
Gain (Loss) on Sale of Investments | - | - | - | - | -410.7 | 176.9 |
Other Unusual Items | -1,369 | -484 | -861 | -68 | -244.6 | -1,048 |
Pretax Income | 34,769 | 25,731 | 12,680 | 6,554 | 6,806 | 6,156 |
Income Tax Expense | 7,189 | 5,091 | 2,090 | 1,314 | 561.6 | 573.8 |
Earnings From Continuing Operations | 27,580 | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income | 27,580 | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income to Common | 27,580 | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income Growth | 49.80% | 94.90% | 102.10% | -16.09% | 11.88% | -9.88% |
Shares Outstanding (Basic) | 894 | 897 | 901 | 900 | 902 | 907 |
Shares Outstanding (Diluted) | 895 | 899 | 904 | 903 | 905 | 912 |
Shares Change | -0.58% | -0.53% | 0.09% | -0.15% | -0.78% | -0.09% |
EPS (Basic) | 30.86 | 23.00 | 11.76 | 5.82 | 6.93 | 6.15 |
EPS (Diluted) | 30.81 | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 |
EPS Growth | 50.73% | 95.99% | 101.90% | -15.94% | 12.75% | -9.87% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 19,661 | 8,972 | 3,760 | 792 | 5,731 | 6,056 |
Free Cash Flow Per Share | 21.96 | 9.98 | 4.16 | 0.88 | 6.34 | 6.64 |
Dividend Per Share | 6.690 | 6.000 | 5.200 | 4.520 | 3.920 | 3.400 |
Dividend Growth | 15.35% | 15.38% | 15.04% | 15.31% | 15.29% | 14.87% |
Gross Margin | 83.63% | 83.04% | 81.31% | 79.25% | 76.77% | 75.38% |
Operating Margin | 51.25% | 45.56% | 37.83% | 30.26% | 30.32% | 29.21% |
Profit Margin | 31.90% | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% |
Free Cash Flow Margin | 22.74% | 13.76% | 8.35% | 2.32% | 20.08% | 21.39% |
EBITDA | 46,489 | 31,693 | 18,807 | 11,852 | 10,176 | 9,820 |
EBITDA Margin | 53.77% | 48.63% | 41.75% | 34.73% | 35.65% | 34.68% |
D&A For EBITDA | 2,174 | 1,997 | 1,767 | 1,527 | 1,523 | 1,548 |
EBIT | 44,315 | 29,696 | 17,040 | 10,325 | 8,653 | 8,273 |
EBIT Margin | 51.25% | 45.56% | 37.83% | 30.26% | 30.32% | 29.21% |
Effective Tax Rate | 20.68% | 19.79% | 16.48% | 20.05% | 8.25% | 9.32% |
Advertising Expenses | - | - | - | - | 966.8 | 1,240 |